exRNAdisease

Entry Detail

---



General Information

Database ID: exR0761937 RNA Name: PHB2 RNA Type: mRNA Chromosome: chr12 Starnd: - Coordinate: Start Site(bp): 6965327 End Site(bp): 6970753 External Links: ENSG00000215021

Disease Information

Disease Name: Glioblastoma Multiforme Disease Category: Cancers MeSH ID: D005909 Type: Neoplasms/Neoplasms, Glandular and Epithelial Alias: Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell

Expression Detail

GEO ID: GSE106804 Description: Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles Experimental Design: Cancer vs Control Case Disease Type: Glioblastoma Multiforme Case Disease SubType: NA Case Sample: Glioblastoma Multiforme Control Sample: Healthy Number of Case: 13 Number of Control: 6 Number of Samples: 19

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand AAMP chr2 218264123 218270257 - ABL1 chr9 130713016 130887675 + ABT1 chr6 26596953 26600739 + AC004832.3 chr22 30409255 30428990 + AC006064.6 chr12 6556886 6607367 - AC007192.1 chr19 18153158 18178117 + AC010422.3 chr19 12643831 12648397 - AC011511.1 chr19 10305427 10316009 - AC093525.1 chr16 2513965 2527955 + AC245033.1 chr15 82536788 82573194 - ACAT1 chr11 108116695 108147603 + ACIN1 chr14 23058564 23095614 - ACTB chr7 5527148 5563784 - ACTG1 chr17 81509971 81523847 - ACTN4 chr19 38647649 38731589 + ADAR chr1 154582057 154628013 - ADCY1 chr7 45574140 45723116 + ADCY2 chr5 7396138 7830081 + ADCY3 chr2 24819169 24919839 - ADD2 chr2 70607618 70768225 - ADGRL2 chr1 81306160 81992436 + ADNP2 chr18 80109262 80147523 + AHRR chr5 271670 438291 + AL021546.1 chr12 120438198 120460006 + ALAS1 chr3 52198086 52214327 + ALDOA chr16 30064164 30070457 + miRNA targets: miRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa-miR-491-5p chr9 20716120 20716141 + hsa-miR-625-5p chr14 65471116 65471136 + hsa-miR-744-5p chr17 12081909 12081930 + circRNA targets: NA lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC002116.1 chr19 36008638 36014235 - AC006064.5 chr12 6510275 6510522 + AC010642.2 chr19 58309727 58327248 - AC016876.2 chr17 7581964 7584086 - AC023509.1 chr12 53441741 53467528 + AC091564.7 chr11 6610883 6616594 - AC139149.1 chr17 81514047 81527776 + AC245033.4 chr15 82533175 82540008 - AD000090.1 chr19 35557956 35581954 + Display:

Experiment Detail

GEO ID: NA Sample Source: NA Source Fraction: NA Platform: NA Method: NA Num of detected RNA Type: NA Num of detected RNAs of this Type: NA Sample treatment protocol: NA RNA Extract protocol: NA RNA library preparation protocol: NA

Reference

PMID: 29330365 Title: Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles. Author: Re¨¢tegui E, van der Vos KE, Lai CP, Zeinali M, Atai NA, Aldikacti B, Floyd FP Jr, H Khankhel A, Thapar V, Hochberg FH, Sequist LV, Nahed BV, S Carter B, Toner M, Balaj L, T Ting D, Breakefield XO, Stott SL. Journal: Nat Commun. 2018 Jan 12;9(1):175. Description: Tumor-derived EVs have the potential to be utilized as disease-specific biomarkers, and genes specific to GBM as well as transcripts that are hallmarks for the four genetic subtypes of the disease.